Bonney Michael W
SEC-identified person · CIK 1219016 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vital Therapies INC VTL | Director | filed 2026–2026 |
| Autolus Therapeutics plc AUTL | Director | filed 2026–2026 |
| Alnylam Pharmaceuticals, INC. ALNY | Director · Executive Chair | filed 2014–2025 |
| Bristol Myers Squibb CO BMY | Director | filed 2019–2021 |
| Kaleido Biosciences, Inc. KLDO | Director · Executive Chair | filed 2019–2021 |
| Magenta Therapeutics, Inc. MGTA | Director | filed 2018–2021 |
| Sarepta Therapeutics, Inc. SRPT | Director | filed 2017–2020 |
| Celgene Corp /DE/ CELG | Director | filed 2015–2019 |
| Syros Pharmaceuticals, Inc. SYRS | Director | filed 2018–2019 |
| Global Blood Therapeutics, Inc. GBT | Director | filed 2016–2016 |
| Abrdn World Healthcare Fund THW | Director | filed 2015–2015 |
| NPS Pharmaceuticals INC NSPS | Director | filed 2006–2015 |
| Cubist Pharmaceuticals INC cbst | Director · President and CEO | filed 2006–2015 |
| Abrdn Healthcare Opportunities Fund THQ | Director | filed 2014–2014 |
| Abrdn Healthcare Investors hqh | Director | filed 2011–2014 |
| Abrdn Life Sciences Investors HQL | Director | filed 2011–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.